SCHEMBL8869839

SCHEMBL8869839

COC(=O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2cccc(CCNC(=O)CCc3ccccc3)c2)cn1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 4/20 0.46
RAB9A P51151 3/20 0.41
HIF1A Q16665 2/20 0.41
NPC1 O15118 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 2/20 0.40
LMNA P02545 2/20 0.40
PPARA Q07869 1/20 0.40
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
MAPT P10636 1/20 0.39
ALDH1A1 P00352 2/20 0.39
POLB P06746 1/20 0.39
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868968 0.93 P4HTM (0.47) P4HTMRAB9AHIF1ANPC1SMN1; SMN2
SCHEMBL8868114 0.93 P4HTM (0.42) P4HTMHIF1ASMN1; SMN2LMNAALDH1A1
SCHEMBL8868359 0.93 P4HTM (0.48) P4HTMRAB9AHIF1ANPC1SMN1; SMN2
SCHEMBL8870568 0.91 P4HTM (0.47) P4HTMRAB9AHIF1ANPC1SMN1; SMN2
SCHEMBL8869834 0.91 P4HTM (0.48) P4HTMRAB9AHIF1ANPC1SMN1; SMN2
SCHEMBL9139292 0.90 P4HTM (0.49) P4HTMRAB9ANPC1SMN1; SMN2KDM4E
SCHEMBL8869980 0.89 RAB9A (0.51) P4HTMRAB9AHIF1ANPC1SMN1; SMN2
SCHEMBL8869629 0.89 P4HTM (0.45) P4HTMRAB9AHIF1ANPC1SMN1; SMN2
SCHEMBL8868628 0.89 P4HTM (0.50) P4HTMRAB9AHIF1ANPC1SMN1; SMN2
SCHEMBL9139301 0.88 P4HTM (0.61) P4HTMRAB9AHIF1ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed